Zhao, Jing-lin <br/><br/>
Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion.  [electronic resource] 

 -  Coronary artery disease  Aug 2006 
 - 463-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0954-6928 
<br/><br/><label>Standard No.: </label>10.1097/00019501-200608000-00010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Blood Flow Velocity--drug effects<br/>Chemoprevention<br/>Endothelium--drug effects<br/>Fosinopril--pharmacology<br/>H(+)-K(+)-Exchanging ATPase--drug effects<br/>Models, Animal<br/>Myocardial Infarction--prevention & control<br/>Myocardial Reperfusion<br/>Myocardium<br/>Swine<br/>Tetrazoles--pharmacology<br/>Time Factors<br/>Valine--analogs & derivatives<br/>Valsartan